Every FDA & clinical catalyst, fused with smart-money positioning and a self-grading timing signal — so you ride the anticipation and exit before the binary.
ClinicalTrials.gov, SEC 8-Ks and openFDA fused into one calendar — duplicates collapsed, each date carrying a confidence tier. Coverage you can trust.
Our sell-the-news ladder places each catalyst on its anticipation curve — enter early, exit before the event. This is the validated edge.
Will the data read out positive — good enough to advance or win approval? Published base rates for each phase and disease area, with an experimental model lean on top, graded forward against real outcomes. Context on the science, never an oracle.
We log every call before the event and grade it as the catalyst resolves — a live, public track record. The edges are honest: a real, modest tilt, not a crystal ball. That transparency is the whole point.
PDUFA, ad-comms, readouts and trial completions — filterable, dated, months ahead.
Where each catalyst sits on its run-up curve, right now: watch, enter, or already priced-in.
The odds a catalyst actually pops the stock — from what similar past catalysts did, plus how smart money is positioned.
Short interest, insider buys/sells, and institutional accumulation per name.
Upcoming and just-priced biotech IPOs — filed, expected, and debuted.
The strongest small/mid-cap setups, ranked — the coin-flip names filtered out.
Start with the near-term calendar and this month’s top catalyst. Go Pro for the signals, positioning, screener, and the live track record.